Control Bionics Limited (ASX:CBL)
0.0580
-0.0020 (-3.33%)
Aug 28, 2026, 3:27 PM AEST
Control Bionics Revenue
In the fiscal year ending June 30, 2026, Control Bionics had annual revenue of 5.40M AUD, down -12.11%. Control Bionics had revenue of 2.82M in the half year ending December 31, 2025, a decrease of -4.86%.
Revenue
5.40M
Revenue Growth
-23.28%
P/S Ratio
4.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
26.72M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 5.40M | -743.96K | -12.11% |
| Jun 30, 2025 | 6.14M | 794.13K | 14.84% |
| Jun 30, 2024 | 5.35M | -291.61K | -5.17% |
| Jun 30, 2023 | 5.64M | 1.14M | 25.33% |
| Jun 30, 2022 | 4.50M | 413.43K | 10.11% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compumedics | 61.88M |
| Nova Eye Medical | 33.05M |
| CleanSpace Holdings | 20.66M |
| Micro-X | 16.90M |
| ImpediMed | 14.23M |
| CONNEQT Health | 5.80M |
| Atomo Diagnostics | 3.92M |
| OncoSil Medical | 3.72M |